217 related articles for article (PubMed ID: 33390793)
1. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.
Mistry H; Hsieh G; Buhrlage SJ; Huang M; Park E; Cuny GD; Galinsky I; Stone RM; Gray NS; D'Andrea AD; Parmar K
Mol Cancer Ther; 2013 Dec; 12(12):2651-62. PubMed ID: 24130053
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
[No Abstract] [Full Text] [Related]
5. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression.
Wang L; Man N; Sun XJ; Tan Y; García-Cao M; Liu F; Hatlen M; Xu H; Huang G; Mattlin M; Mehta A; Rampersaud E; Benezra R; Nimer SD
Blood; 2015 Jul; 126(5):640-50. PubMed ID: 26084673
[TBL] [Abstract][Full Text] [Related]
6. Potential efficacy and prognosis of silencing the CRLF2‑mediated AKT/mTOR pathway in pediatric acute B‑cell lymphoblastic leukemia.
Jiang M; Zou X; Lu L
Oncol Rep; 2019 Feb; 41(2):885-894. PubMed ID: 30535452
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway.
Yang G; Zhang Y; Xiong J; Wu J; Yang C; Huang H; Zhu Z
Mol Med Rep; 2012 Apr; 5(4):1075-9. PubMed ID: 22245935
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
9. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro.
Li W; Wang H; Kuang CY; Zhu JK; Yu Y; Qin ZX; Liu J; Huang L
Mol Cell Biochem; 2012 Apr; 363(1-2):135-45. PubMed ID: 22139302
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing of USP1 by lentivirus effectively inhibits proliferation and invasion of human osteosarcoma cells.
Liu J; Zhu H; Zhong N; Jiang Z; Xu L; Deng Y; Jiang Z; Wang H; Wang J
Int J Oncol; 2016 Dec; 49(6):2549-2557. PubMed ID: 27840911
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen-mediated attenuation of stemness.
Lu Z; Zhang Z; Yang M; Xiao M
Anticancer Drugs; 2022 Aug; 33(7):622-631. PubMed ID: 35324534
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/Akt pathway upregulates Id1 and integrin α4 to enhance recruitment of human ovarian cancer endothelial progenitor cells.
Su Y; Zheng L; Wang Q; Bao J; Cai Z; Liu A
BMC Cancer; 2010 Aug; 10():459. PubMed ID: 20796276
[TBL] [Abstract][Full Text] [Related]
13. USP1 promotes the aerobic glycolysis and progression of T-cell acute lymphoblastic leukemia via PLK1/LDHA axis.
Liu S; Xiang Y; Wang B; Gao C; Chen Z; Xie S; Wu J; Liu Y; Zhao X; Yang C; Yue Z; Wang L; Wen X; Zhang R; Zhang F; Xu H; Zhai X; Zheng H; Zhang H; Qian M
Blood Adv; 2023 Jul; 7(13):3099-3112. PubMed ID: 36912760
[TBL] [Abstract][Full Text] [Related]
14. Interaction between CD9 and PI3K‑p85 activates the PI3K/AKT signaling pathway in B‑lineage acute lymphoblastic leukemia.
Shi YF; Huang ZY; Huang YS; Dong RJ; Xing CY; Yu K; Leung KT; Feng JH
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036396
[TBL] [Abstract][Full Text] [Related]
15. FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1.
Birkenkamp KU; Essafi A; van der Vos KE; da Costa M; Hui RC; Holstege F; Koenderman L; Lam EW; Coffer PJ
J Biol Chem; 2007 Jan; 282(4):2211-20. PubMed ID: 17132628
[TBL] [Abstract][Full Text] [Related]
16. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
[TBL] [Abstract][Full Text] [Related]
17. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway.
Cai J; Liu T; Huang P; Yan W; Guo C; Xiong L; Liu A
Biochem Biophys Res Commun; 2017 Apr; 486(1):184-190. PubMed ID: 28286270
[TBL] [Abstract][Full Text] [Related]
18. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
19. Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
Yu G; Yin C; Jiang L; Zheng Z; Wang Z; Wang C; Zhou H; Jiang X; Liu Q; Meng F
Oncol Rep; 2016 Sep; 36(3):1626-32. PubMed ID: 27460334
[TBL] [Abstract][Full Text] [Related]
20. USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation.
Goldbraikh D; Neufeld D; Eid-Mutlak Y; Lasry I; Gilda JE; Parnis A; Cohen S
EMBO Rep; 2020 Apr; 21(4):e48791. PubMed ID: 32133736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
